New York, NY, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Pharmaceutical Continuous Manufacturing Market by Application (Active Pharmaceutical Ingredient, Biologics, and Dry Powders), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by End-users (Pharmaceutical Companies and Contract Manufacturing Organization): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024”. According to the report, global pharmaceutical continuous manufacturing market was valued at approximately USD 1934.0 million in 2017 and is expected to generate revenue of around USD 3406.0 million by the end of 2024, growing at a CAGR of around 8.4% between 2018 and 2024.
The manufacturing process of pharmaceutical products without any kind of interruption is referred to as continuous manufacturing. Continuous manufacturing is the opposite of batch manufacturing. It is also known as flow production; where the manufacturing is carried out in one go. Product recalls and shortages of drugs at unprecedented rates have occurred in the U.S. over the past decade. This is restricting patient access to vital medications and is undermining health care. The significant reason behind these recalls and shortages has been due to quality issues of manufacturing.
Browse through 72 Tables & 20 Figures spread over 110 Pages and in-depth TOC on “Global Pharmaceutical Continuous Manufacturing Market by Type, Size, Share, Industry Trends and Forecast 2017 - 2024”.
Request Free Sample Report of Global Pharmaceutical Continuous Manufacturing Market Report @ https://www.zionmarketresearch.com/sample/pharmaceutical-continuous-manufacturing-market
In the continuous manufacturing process, the raw material is inserted into the system and the final product is produced in a continuous manner. Continuous manufacturing processes have a number of benefits over the batch manufacturing process. As the continuous manufacturing is more flexible and agile, due to which the changes in supply or demand can be responded more quickly. This is majorly beneficial in emergency circumstances such as critical drug shortages for vital or epidemic outbreaks. The rapid increase in production volume and higher process safety by using a continuous manufacturing process will significantly drive the market over the forecast period. However, the difficulties in the adoption of a continuous process over the batch production process will limit the market growth during the forecast period.
The pharmaceutical continuous manufacturing market is segmented on the basis of application into an active pharmaceutical ingredient, dry powders, and biologics. The biologics application segment is expected to contribute to the largest share in the global pharmaceutical continuous manufacturing market owing to the high demand for biologics worldwide.
Download Free Report PDF Brochure: https://www.zionmarketresearch.com/requestbrochure/pharmaceutical-continuous-manufacturing-market
Based on the distribution channel, global pharmaceutical continuous manufacturing market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy. Retail pharmacy segment is expected to hold the major share by distribution channel during the forecast period. Whereas the online pharmacy segment is anticipated to grow at the highest CAGR owing to the increasing preferences for e-commerce platforms together with benefits provided by online pharmacies such as home delivery and other discount offers.
By end-user, the market is segmented into pharmaceutical companies and contract manufacturing organization. The pharmaceutical companies are anticipated to contribute to the largest share for the global pharmaceutical continuous manufacturing market during the forecast period. Whereas, the contract manufacturing organization is expected to register the highest CAGR owing to an increasing base of contract manufacturing organization in developing nations.
Request for Discount on This Report: https://www.zionmarketresearch.com/requestdiscount/pharmaceutical-continuous-manufacturing-market
Europe dominates the pharmaceutical continuous manufacturing market due to favorable government frameworks and a high number of pharmaceutical manufacturing companies. The UK and Germany are the prominent countries responsible for driving the pharmaceutical continuous manufacturing in the European region. High adoption of the automated and technologically advanced process to utilize the maximum production capacity will propel the growth of the market in the region over the forecast period.
North America holds the second largest regional market and is expected to show significant growth in the years to come due to increasing favorable government regulations. Moreover, high investment, demand and acceptance of advanced technology from pharmaceutical companies will significantly boost the pharmaceutical continuous manufacturing market in the North America region.
Browse the full "Pharmaceutical Continuous Manufacturing Market by Application (Active Pharmaceutical Ingredient, Biologics, and Dry Powders), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by End-users (Pharmaceutical Companies and Contract Manufacturing Organization): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024" report at https://www.zionmarketresearch.com/report/pharmaceutical-continuous-manufacturing-market
Furthermore, the U.S. is expected to dominate the North America pharmaceutical continuous manufacturing market throughout the forecast period.
The Asia Pacific pharmaceutical continuous manufacturing market is projected to have the highest CAGR during the forecast period. The market is particularly expected to be driven by China, India, and other emerging countries where the market penetration of pharmaceutical continuous manufacturing is anticipated to be highest. Owing to increasing pharmaceutical manufacturing industries and presence of high number of contract research manufacturing organizations the market will flourish in Asia Pacific region.
Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/pharmaceutical-continuous-manufacturing-market
In Latin America, Brazil contributes to the major market share in the pharmaceutical continuous manufacturing market, owing to the increasing healthcare infrastructure in the region. The Middle East and Africa hold the least growth in comparison to other regions, due to the low industrial growth and lack of government policies in this region, which are responsible for hampering the growth of the market. Thus, all the above-mentioned factors are expected to propel the market growth globally.
Some of the key players in pharmaceutical continuous manufacturing market include Siemens AG, Corning Life Sciences, S K Biotek Ltd., Scott Equipment Company, GEA Group, Korsch AG, Chemtrix, and Continuus Pharmaceuticals, among others.
Request customized copy of report @ https://www.zionmarketresearch.com/custom/3314
This report segments the global pharmaceutical continuous manufacturing market as follows:
Global Pharmaceutical Continuous Manufacturing Market: Application Segment Analysis
- Active Pharmaceutical Ingredient
- Biologics
- Dry Powders
Global Pharmaceutical Continuous Manufacturing Market: Distribution Channel Segment Analysis
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Global Pharmaceutical Continuous Manufacturing Market: End-user Segment Analysis
- Pharmaceutical Companies
- Contract Manufacturing Organization
Global Pharmaceutical Continuous Manufacturing Market: Regional
- North America
- The U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- The Middle East and Africa
Browse Similar Reports:
- Plasma Protein Therapeutic Market: https://www.zionmarketresearch.com/report/plasma-protein-therapeutic-market
- Nutraceutical Excipients Market: https://www.zionmarketresearch.com/report/nutraceutical-excipients-market
- Compounding Pharmacies Market: https://www.zionmarketresearch.com/report/compounding-pharmacies-market
- Epilepsy Therapeutics Market: https://www.zionmarketresearch.com/report/epilepsy-therapeutics-market
- Alzheimer’s Drugs Market: https://www.zionmarketresearch.com/report/alzheimers-drugs-market
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research
Blog: http://www.intenseresearch.com | http://www.mrsresearchgroup.com | http://www.marketresearchtrade.com | https://qyresearchgroup.com | http://marketnreports.com | https://zmrnewsjournal.us | http://www.e-marketresearch.com
Contact Us:
Joel John
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com
Blog: http://zmrblog.com